OP0132 EFFECT OF IBERDOMIDE ON CUTANEOUS MANIFESTATIONS IN SYSTEMIC LUPUS ERYTHEMATOSUS: RESULTS OF A 24-WEEK, PLACEBO-CONTROLLED, PHASE 2 STUDY

作者：Victoria P. Werth, Joan T. Merrill, Richard Furie, Thomas Dörner, Ronald van Vollenhoven, Peter E. Lipsky, Michael Weiswasser, Shimon Korish, Peter Schäfer, Martin Stern, Z. Liu, Shijie Tang, Nikolay Delev · 发表于：Annals of the Rheumatic Diseases · 年份：2021 · DOI：10.1136/annrheumdis-2021-eular.2181 · 被引用次数：8 · 研究领域：Systemic Lupus Erythematosus Research、Chemokine receptors and signaling、Protein Tyrosine Phosphatases